Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion type Assertion NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_head.
- NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion description "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_provenance.
- NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion evidence source_evidence_literature NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_provenance.
- NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion SIO_000772 16232198 NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_provenance.
- NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion wasDerivedFrom lhgdn-20090331 NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_provenance.
- NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_assertion wasGeneratedBy ECO_0000203 NP213676.RAJP-kSqgzrIDQD6XE0LoSv2GNjCbJaca6yHP9aVLhFeM130_provenance.